BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc. financial statements

BioXcel Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 642K10-K
Net income−USD 69.9M10-K
Cash and equivalentsUSD 28.41M10-Q
Total debtUSD 109.59M10-Q

BioXcel Therapeutics, Inc. financials on 6ix · BioXcel Therapeutics, Inc. on 6ix